J9999 Chemotherapy drugNot otherwise classified, antineoplastic drugs
Status E: excluded from the PFS by regulation.
241 of 241 payer prior-auth lists that name J9999 require prior authorization or set conditions: Aetna, Arkansas Blue Cross and Blue Shield, Blue Cross Blue Shield of Arizona (AZ Blue), Blue Cross and Blue Shield of Illinois, Blue Cross and Blue Shield of Texas, Blue Shield of California Promise Health Plan, CarePlus Health Plans, Cigna, HealthSpring, Humana, Molina Complete Care (Virginia), Molina Healthcare of Arizona, Molina Healthcare of California, Molina Healthcare of Florida, Molina Healthcare of Idaho, Molina Healthcare of Illinois, Molina Healthcare of Iowa, Molina Healthcare of Michigan, Molina Healthcare of Mississippi, Molina Healthcare of Nevada, and others.
| Payer | Plan | State | Prior auth | Conditions | Since | Source |
|---|---|---|---|---|---|---|
| Arkansas Blue Cross and Blue Shield | Drugs under the medical benefit (not ASE/PSE or FEP, which use EBRx and Prime) | AR | prior auth under conditions | Unlisted drug code: PA for Amtagvi | Jul 1, 2024 | Medical Benefit Pharmacy Prior Approval List |
| Blue Cross Blue Shield of Arizona (AZ Blue) | AZ Blue-administered Medicare Advantage (M2K) | AZ | prior auth under conditions | Unclassified code: PA only for the listed drugs | Sep 1, 2026 | AZ Blue Medicare Advantage Prior Authorization Requirements Code List (Effective 09/01/2026) |
| Blue Cross Blue Shield of Arizona (AZ Blue) | Federal Employee Program (FEP) | AZ | prior auth under conditions | Unclassified code: PA only for the listed drugs | Sep 1, 2026 | Federal Employee Program (FEP) Prior Authorization Requirements Code List (Updated 09/01/2026) |
| Blue Cross Blue Shield of Arizona (AZ Blue) | Standard PA code list (most commercial plans) | AZ | prior auth under conditions | Unclassified code: PA only for the listed drugs | Sep 1, 2026 | AZ Blue Standard Prior Authorization Requirements Code List (09/01/2026) |
| Blue Cross Blue Shield of Arizona (AZ Blue) | State of Arizona employee group (SYD, S3Z) | AZ | prior auth under conditions | Unclassified code: PA only for the listed drugs | Sep 1, 2026 | State of Arizona Group Prior Authorization Requirements Code List (09/01/2026) |
| Blue Cross Blue Shield of Arizona (AZ Blue) | Teamsters group (TYW) | AZ | prior auth under conditions | Unclassified code: PA only for the listed drugs | Sep 1, 2026 | Teamsters Group Prior Authorization Requirements Code List (Updated 09/01/2026) |
| Blue Shield of California Promise Health Plan | Promise Health Plan Medi-Cal | CA | prior auth under conditions | Unlisted drug code: PA for the listed drug(s) | Sep 1, 2026 | Medi-Cal Prior Authorization List |
| Aetna | Medicare Advantage | All | prior auth under conditions | When billed for Amtagvi | Aug 25, 2026 | Aetna Medicare Part B drug list (partbname.xml) |
| Aetna | Medicare Advantage | All | prior auth under conditions | When billed for Avzivi; Step therapy applies | Aug 25, 2026 | Aetna Medicare Part B drug list (partbname.xml) |
| Aetna | Medicare Advantage | All | prior auth under conditions | When billed for Revtorpyk | Aug 25, 2026 | Aetna Medicare Part B drug list (partbname.xml) |
| Aetna | Medicare Advantage | All | prior auth under conditions | When billed for Sarclisa Escena SC | Aug 25, 2026 | Aetna Medicare Part B drug list (partbname.xml) |
| Aetna | Commercial | All | prior auth under conditions | site of care: drug and site of care | Oct 1, 2026 | Participating provider precertification list for Aetna® |
| Aetna | Commercial | All | prior auth under conditions | site of care: drug and site of care | Oct 1, 2026 | Participating provider precertification list for Aetna® |
| Aetna | Commercial | All | prior auth under conditions | When billed for Revtorpyk | Sep 1, 2026 | Participating provider precertification list for Aetna® |
| Aetna | Commercial | All | prior auth under conditions | When billed for Sarclisa Escena SC | Sep 1, 2026 | Participating provider precertification list for Aetna® |
| Aetna | Commercial | All | prior auth under conditions | site of care: drug and site of care | Apr 1, 2026 | Participating provider precertification list for Aetna® |
| Aetna | Commercial | All | prior auth under conditions | site of care: drug and site of care | Oct 1, 2026 | Participating provider precertification list for Aetna® |
| Aetna | Commercial | All | prior auth under conditions | When billed for Lytenava | Sep 1, 2026 | Participating provider precertification list for Aetna® |
| Aetna | Medicare Advantage | All | prior auth under conditions | When billed for Amtagvi | Oct 1, 2026 | Participating provider precertification list for Aetna® |
| Aetna | Medicare Advantage | All | prior auth under conditions | When billed for Avzivi | Oct 1, 2026 | Participating provider precertification list for Aetna® |
| Aetna | Medicare Advantage | All | prior auth under conditions | When billed for Revtorpyk | Sep 1, 2026 | Participating provider precertification list for Aetna® |
| Aetna | Medicare Advantage | All | prior auth under conditions | When billed for Sarclisa Escena SC | Sep 1, 2026 | Participating provider precertification list for Aetna® |
| Aetna | Medicare Advantage | All | prior auth under conditions | When billed for Poherdy | Apr 1, 2026 | Participating provider precertification list for Aetna® |
| Aetna | Medicare Advantage | All | prior auth under conditions | When billed for Zimrixby | Oct 1, 2026 | Participating provider precertification list for Aetna® |
| Aetna | Medicare Advantage | All | prior auth under conditions | When billed for Lytenava | Sep 1, 2026 | Participating provider precertification list for Aetna® |
| Aetna | Medicare Advantage | All | prior auth under conditions | When billed for Decnupaz (pivekimab sunirine-pvzy) | Aug 25, 2026 | Aetna Medicare Part B drug list (partbname.xml) |
| Aetna | Medicare Advantage | All | prior auth under conditions | When billed for Omisirge | Aug 25, 2026 | Aetna Medicare Part B drug list (partbname.xml) |
| Aetna | Medicare Advantage | All | prior auth under conditions | When billed for Lytenava | Aug 25, 2026 | Aetna Medicare Part B drug list (partbname.xml) |
| Aetna | Medicare Advantage | All | prior auth under conditions | When billed for Lunsumio Velo | Aug 25, 2026 | Aetna Medicare Part B drug list (partbname.xml) |
| Aetna | Medicare Advantage | All | prior auth under conditions | When billed for Lantidra | Aug 25, 2026 | Aetna Medicare Part B drug list (partbname.xml) |
| Aetna | Medicare Advantage | All | prior auth under conditions | When billed for Evdi (trabectedin) | Aug 25, 2026 | Aetna Medicare Part B drug list (partbname.xml) |
| Aetna | Medicare Advantage | All | prior auth under conditions | When billed for Poherdy | Aug 25, 2026 | Aetna Medicare Part B drug list (partbname.xml) |
| Cigna | ACA/IFP | All | prior auth required | eviCore Medical Oncology Program for oncology diagnoses; Cigna for other indications; May be delegated to eviCore for some clients | Feb 17, 2017 | Master Precertification List (For Health Care Providers) |
| Cigna | Basic Standard | All | prior auth required | eviCore Medical Oncology Program for oncology diagnoses; Cigna for other indications; May be delegated to eviCore for some clients | Feb 17, 2017 | Master Precertification List (For Health Care Providers) |
| Cigna | Complete/PHS+/Preferred | All | prior auth required | eviCore Medical Oncology Program for oncology diagnoses; Cigna for other indications; May be delegated to eviCore for some clients | Feb 17, 2017 | Master Precertification List (For Health Care Providers) |
| Blue Cross and Blue Shield of Illinois | Blue Cross Community Health Plans (BCCHP), Illinois Medicaid | IL | prior auth required | Jan 1, 2026 | Illinois Medicaid Prior Authorization Code List, Effective 10/1/2026 | |
| Blue Cross and Blue Shield of Illinois | Blue Cross Community MMAI (Medicare-Medicaid Alignment Initiative) | IL | prior auth required | Jan 1, 2024 | Procedure Code List, Effective 1/1/2025 | |
| Blue Cross and Blue Shield of Texas | Texas PA exemption (gold card), outpatient, fully insured | TX | prior auth required | Gold-card exemption available | Jul 1, 2026 | BCBSTX Outpatient Prior Authorization Exemption Clinical Guidelines (max units, PA exempt date range) |
| HealthSpring | Medicare Advantage | All | prior auth required | Jan 1, 2025 | 2026 Q4 Prior Authorization List | |
| CarePlus Health Plans | CarePlus Health Plans | FL | prior auth under conditions | NOC code: PA when billed for Revtorpyk; NDC required | Jan 1, 2027 | Medicare Advantage and Dual Eligible Special Needs Plans Prior Authorization and Notification List We have updated our CarePlus Health Plans Prior Authorization and Notification List for CarePlus Medi |
| CarePlus Health Plans | CarePlus Health Plans | FL | prior auth under conditions | NOC code: PA when billed for Decnupaz | Jan 1, 2027 | Medicare Advantage and Dual Eligible Special Needs Plans Prior Authorization and Notification List We have updated our CarePlus Health Plans Prior Authorization and Notification List for CarePlus Medi |
| CarePlus Health Plans | CarePlus Health Plans | FL | prior auth under conditions | NOC code: PA when billed for Tregzi; NDC required | Jan 1, 2027 | Medicare Advantage and Dual Eligible Special Needs Plans Prior Authorization and Notification List We have updated our CarePlus Health Plans Prior Authorization and Notification List for CarePlus Medi |
| CarePlus Health Plans | CarePlus Health Plans | FL | prior auth under conditions | NOC code: PA when billed for Tudriqev; NDC required | Jan 1, 2027 | Medicare Advantage and Dual Eligible Special Needs Plans Prior Authorization and Notification List We have updated our CarePlus Health Plans Prior Authorization and Notification List for CarePlus Medi |
| CarePlus Health Plans | CarePlus Health Plans | FL | prior auth under conditions | NOC code: PA when billed for Unituxin; NDC required | Jan 1, 2027 | Medicare Advantage and Dual Eligible Special Needs Plans Prior Authorization and Notification List We have updated our CarePlus Health Plans Prior Authorization and Notification List for CarePlus Medi |
| CarePlus Health Plans | CarePlus Health Plans | FL | prior auth under conditions | NOC code: PA when billed for Amtagvi; NDC required | Jan 1, 2027 | Medicare Advantage and Dual Eligible Special Needs Plans Prior Authorization and Notification List We have updated our CarePlus Health Plans Prior Authorization and Notification List for CarePlus Medi |
| CarePlus Health Plans | CarePlus Health Plans | FL | prior auth required | Jan 1, 2027 | Medicare Advantage and Dual Eligible Special Needs Plans Prior Authorization and Notification List | |
| CarePlus Health Plans | CarePlus Health Plans | FL | prior auth under conditions | NOC code: PA when billed for Cligavyx; NDC required | Jan 1, 2027 | Medicare Advantage and Dual Eligible Special Needs Plans Prior Authorization and Notification List We have updated our CarePlus Health Plans Prior Authorization and Notification List for CarePlus Medi |
| CarePlus Health Plans | CarePlus Health Plans | FL | prior auth under conditions | NOC code: PA when billed for Sarclisa Escena; NDC required | Jan 1, 2027 | Medicare Advantage and Dual Eligible Special Needs Plans Prior Authorization and Notification List We have updated our CarePlus Health Plans Prior Authorization and Notification List for CarePlus Medi |
| CarePlus Health Plans | CarePlus Health Plans | FL | prior auth under conditions | NOC code: PA when billed for Evdi | Jan 1, 2027 | Medicare Advantage and Dual Eligible Special Needs Plans Prior Authorization and Notification List We have updated our CarePlus Health Plans Prior Authorization and Notification List for CarePlus Medi |
| Humana | Humana D-SNP (FL) | FL | prior auth under conditions | NOC code: PA when billed for Cligavyx; NDC required | Jul 1, 2026 | H1036-280 Humana Fully Integrated Florida prior authorization and notification list |
| Humana | Humana D-SNP (FL) | FL | prior auth under conditions | NOC code: PA when billed for Decnupaz; New PA requirement; NDC required | Jul 1, 2026 | H1036-280 Humana Fully Integrated Florida prior authorization and notification list |
| Humana | Humana D-SNP (FL) | FL | prior auth under conditions | NOC code: PA when billed for Unituxin; NDC required | Jul 1, 2026 | H1036-280 Humana Fully Integrated Florida prior authorization and notification list |
| Humana | Humana D-SNP (FL) | FL | prior auth under conditions | NOC code: PA when billed for Tudriqev; NDC required | Jul 1, 2026 | H1036-280 Humana Fully Integrated Florida prior authorization and notification list |
| Humana | Humana D-SNP (FL) | FL | prior auth under conditions | NOC code: PA when billed for Tregzi; Transplant network review; NDC required | Jul 1, 2026 | H1036-280 Humana Fully Integrated Florida prior authorization and notification list |
| Humana | Humana D-SNP (FL) | FL | prior auth under conditions | NOC code: PA when billed for Sarclisa Escena; NDC required | Jul 1, 2026 | H1036-280 Humana Fully Integrated Florida prior authorization and notification list |
| Humana | Humana D-SNP (FL) | FL | prior auth under conditions | NOC code: PA when billed for Revtorpyk; NDC required | Jul 1, 2026 | H1036-280 Humana Fully Integrated Florida prior authorization and notification list |
| Humana | Humana D-SNP (FL) | FL | prior auth under conditions | NOC code: PA when billed for Evdi; NDC required | Jul 1, 2026 | H1036-280 Humana Fully Integrated Florida prior authorization and notification list |
| Humana | Humana D-SNP (FL) | FL | prior auth required | Jan 1, 2027 | 1 *New prior authorization requirement 787403FL0725 FLHMQSREN Humana Dual Fully Integrated Florida Prior Authorization and Notification List | |
| Humana | Humana D-SNP (FL) | FL | prior auth under conditions | NOC code: PA when billed for Amtagvi; Transplant network review; NDC required | Jul 1, 2026 | H1036-280 Humana Fully Integrated Florida prior authorization and notification list |
| Humana | Humana D-SNP (IL) | IL | prior auth under conditions | NOC code: PA when billed for Evdi; NDC required | Jan 1, 2027 | Humana Dual Fully Integrated Illinois prior authorization and notification list |
| Humana | Humana D-SNP (IL) | IL | prior auth under conditions | NOC code: PA when billed for Revtorpyk; NDC required | Jan 1, 2027 | Humana Dual Fully Integrated Illinois prior authorization and notification list |
| Humana | Humana D-SNP (IL) | IL | prior auth under conditions | NOC code: PA when billed for Sarclisa Escena; NDC required | Jan 1, 2027 | Humana Dual Fully Integrated Illinois prior authorization and notification list |
| Humana | Humana D-SNP (IL) | IL | prior auth under conditions | NOC code: PA when billed for Tregzi; Transplant network review; NDC required | Jan 1, 2027 | Humana Dual Fully Integrated Illinois prior authorization and notification list |
| Humana | Humana D-SNP (IL) | IL | prior auth under conditions | NOC code: PA when billed for Tudriqev; NDC required | Jan 1, 2027 | Humana Dual Fully Integrated Illinois prior authorization and notification list |
| Humana | Humana D-SNP (IL) | IL | prior auth under conditions | NOC code: PA when billed for Amtagvi; Transplant network review; NDC required | Jan 1, 2027 | Humana Dual Fully Integrated Illinois prior authorization and notification list |
| Humana | Humana D-SNP (IL) | IL | prior auth required | Jan 1, 2027 | Humana Dual Fully Integrated Illinois Prior Authorization and Notification List | |
| Humana | Humana D-SNP (IL) | IL | prior auth under conditions | NOC code: PA when billed for Decnupaz; NDC required | Jan 1, 2027 | Humana Dual Fully Integrated Illinois prior authorization and notification list |
| Humana | Humana D-SNP (IL) | IL | prior auth under conditions | NOC code: PA when billed for Cligavyx; NDC required | Jan 1, 2027 | Humana Dual Fully Integrated Illinois prior authorization and notification list |
| Humana | Humana D-SNP (IL) | IL | prior auth under conditions | NOC code: PA when billed for Unituxin; NDC required | Jan 1, 2027 | Humana Dual Fully Integrated Illinois prior authorization and notification list |
| Humana | Humana D-SNP (IN) | IN | prior auth under conditions | NOC code: PA when billed for Decnupaz; NDC required | Jan 1, 2027 | Humana PathWays Dual Care (HMO-POS D-SNP) prior authorization and notification list Important notes: |
| Humana | Humana D-SNP (IN) | IN | prior auth under conditions | NOC code: PA when billed for Cligavyx; NDC required | Jan 1, 2027 | Humana PathWays Dual Care (HMO-POS D-SNP) prior authorization and notification list Important notes: |
| Humana | Humana D-SNP (IN) | IN | prior auth under conditions | NOC code: PA when billed for Unituxin; NDC required | Jan 1, 2027 | Humana PathWays Dual Care (HMO-POS D-SNP) prior authorization and notification list Important notes: |
| Humana | Humana D-SNP (IN) | IN | prior auth under conditions | NOC code: PA when billed for Tudriqev; NDC required | Jan 1, 2027 | Humana PathWays Dual Care (HMO-POS D-SNP) prior authorization and notification list Important notes: |
| Humana | Humana D-SNP (IN) | IN | prior auth under conditions | NOC code: PA when billed for Tregzi; Transplant network review; NDC required | Jan 1, 2027 | Humana PathWays Dual Care (HMO-POS D-SNP) prior authorization and notification list Important notes: |
| Humana | Humana D-SNP (IN) | IN | prior auth under conditions | NOC code: PA when billed for Sarclisa Escena; NDC required | Jan 1, 2027 | Humana PathWays Dual Care (HMO-POS D-SNP) prior authorization and notification list Important notes: |
| Humana | Humana D-SNP (IN) | IN | prior auth under conditions | NOC code: PA when billed for Revtorpyk; NDC required | Jan 1, 2027 | Humana PathWays Dual Care (HMO-POS D-SNP) prior authorization and notification list Important notes: |
| Humana | Humana D-SNP (IN) | IN | prior auth under conditions | NOC code: PA when billed for Evdi; NDC required | Jan 1, 2027 | Humana PathWays Dual Care (HMO-POS D-SNP) prior authorization and notification list Important notes: |
| Humana | Humana D-SNP (IN) | IN | prior auth under conditions | NOC code: PA when billed for Amtagvi; Transplant network review; NDC required | Jan 1, 2027 | Humana PathWays Dual Care (HMO-POS D-SNP) prior authorization and notification list Important notes: |
| Humana | Humana D-SNP (IN) | IN | prior auth required | Jan 1, 2027 | *New prior authorization requirement 814403IN0825 H4939_INHN6Z6EN_C Humana PathWays Dual Care (HMO-POS D-SNP) Indiana Prior Authorization and Notification List | |
| Humana | Humana D-SNP (MI) | MI | prior auth under conditions | NOC code: PA when billed for Unituxin; NDC required | Oct 14, 2026 | Humana Dual Integrated (health maintenance organization Dual Eligible Special Needs Plan (HMO D- SNP) Michigan prior authorization and notification list (PAL) |
J9999 appears in 61 coverage policies from Aetna, Blue Cross & Blue Shield of Mississippi, Blue Cross Blue Shield of Massachusetts, BlueCross BlueShield of South Carolina, Centene, Health Care Service Corporation (BCBS IL, TX, OK, NM, MT), Premera Blue Cross, UnitedHealthcare, Wellmark Blue Cross Blue Shield.
| Payer | Policy | Role in policy | Reviewed | Document |
|---|---|---|---|---|
| Aetna | Hematopoietic Cell Transplantation for Hodgkin's Disease (0495) | listed, no stance (range J9000-J9999) | Jul 2, 2026 | payer document |
| Aetna | Hematopoietic Cell Transplantation for Multiple Myeloma (0497) | listed, no stance (range J9000-J9999) | Aug 5, 2026 | payer document |
| Aetna | Hematopoietic Cell Transplantation for Selected Childhood Solid Tumors (0496) | listed, no stance (range J9000-J9999) | Aug 6, 2026 | payer document |
| Aetna | Hematopoietic Cell Transplantation for Thalassemia Major and Sickle Cell Anemia (0626) | listed, no stance (range J9000-J9999) | Sep 18, 2026 | payer document |
| Aetna | Infusion Pumps (0161) | covered if criteria are met (range J9000-J9999) | Mar 31, 2026 | payer document |
| Aetna | Injectable Medications (0020) | listed, no stance (range J9000-J9999) | Mar 5, 2026 | payer document |
| Aetna | Margetuximab-cmkb (Margenza) (0985) | listed, no stance (range J9000-J9999) | May 27, 2026 | payer document |
| Aetna | Negative Pressure Wound Therapy (0334) | listed, no stance (range J9000-J9999) | Jun 8, 2026 | payer document |
| Aetna | Pertuzumab Products (0973) | listed, no stance (range J9000-J9999) | Apr 27, 2026 | payer document |
| Aetna | Phototherapy and Photochemotherapy (PUVA) for Skin Conditions (0205) | listed, no stance (range J9000-J9999) | May 18, 2026 | payer document |
| Aetna | Revakinagene Taroretcel-lwey (Encelto) (1079) | listed, no stance (range J8501-J9999) | Oct 5, 2026 | payer document |
| Aetna | Tumor Chemoresistance Assays (0758) | listed, no stance (range J9000-J9999) | Dec 2, 2025 | payer document |
| Aetna | Tumor Chemosensitivity Assays (0245) | listed, no stance (range J9000-J9999) | Apr 13, 2026 | payer document |
| Blue Cross & Blue Shield of Mississippi | Injectable Oncology (L.5.01.561) | listed, no stance | payer document | |
| Blue Cross & Blue Shield of Mississippi | Injectable Oncology (S.5.01.561) | listed, no stance | payer document | |
| Blue Cross Blue Shield of Massachusetts | CAR T-Cell Therapy Services for the Treatment of Diffuse Large B-cell Lymphoma (axicabtagene cilleucel or tisagenlecleucel) Prior Authorization Request Form #924 | listed, no stance | payer document | |
| BlueCross BlueShield of South Carolina | Adstiladrin (Nadofaragene firadenovec-vncg) (CAM 930) | listed, no stance | May 1, 2026 | payer document |
| BlueCross BlueShield of South Carolina | Amtagvi (lifileucel) (CAM 924) | listed, no stance | Apr 1, 2026 | payer document |
| BlueCross BlueShield of South Carolina | Hematopoietic Cell Transplantation for Breast Cancer (CAM 80127) | listed, no stance (range J9000-J9999) | Jul 1, 2026 | payer document |
| BlueCross BlueShield of South Carolina | Hematopoietic Cell Transplantation for Miscellaneous Solid Tumors in Adults (CAM 80124) | unproven / investigational (range J9000-J9999) | Jul 1, 2026 | payer document |
| BlueCross BlueShield of South Carolina | Hematopoietic Stem-Cell Transplantation for Plasma Cell Dyscrasias, Including Multiple Myeloma and POEMS Syndrome (CAM 80117) | listed, no stance (range J9000-J9999) | Jan 1, 2026 | payer document |
| BlueCross BlueShield of South Carolina | Nivolumab (Opdivo) (CAM 106) | listed, no stance | Jun 1, 2026 | payer document |
| BlueCross BlueShield of South Carolina | Tecelra (afamitresgene autoleucel) (CAM 931) | listed, no stance | Jun 1, 2026 | payer document |
| Centene | Amivantamab-vmjw (Rybrevant), (CP.PHAR.544) Reviews, Revisions, and Approvals | Date | P&T | covered if criteria are met | Aug 1, 2026 | payer document |
| Centene | Bevacizumab (Alymsys, Avastin, Avzivi, Jobevne, Mvasi, Vegzelma, Zirabev) (CP.PHAR.93) | covered if criteria are met | Nov 1, 2025 | payer document |
| Centene | Ciltacabtagene Autoleucel (Carvykti) (CP.PHAR.533) Reviews, Revisions, and Approvals | Date | P&T | covered if criteria are met | May 1, 2026 | payer document |
| Centene | Datopotamab Deruxtecan-dlnk (Datroway) (CP.PHAR.715) RT4: Policy created. | 01.23.25 | 05.25 | covered if criteria are met | May 1, 2026 | payer document |
| Centene | Elranatamab-bcmm (Elrexfio) (CP.PHAR.652) Reviews, Revisions, and Approvals | Date | P&T | covered if criteria are met | Nov 1, 2025 | payer document |
| Centene | Lifileucel (Amtagvi) (CP.PHAR.598) | covered if criteria are met | Nov 1, 2025 | payer document |
| Centene | Linvoseltamab-gcpt (Lynozyfic) (CP.PHAR.743) | covered if criteria are met | Aug 1, 2026 | payer document |
| Centene | Pivekimab Sunirine-pvzy (Decnupaz) (CP.PHAR.785) | covered if criteria are met | Aug 1, 2026 | payer document |
| Centene | Ropeginterferon Alfa-2b-njft (BESREMi) (CP.PHAR.570) | covered if criteria are met | Feb 1, 2026 | payer document |
| Centene | Tebentafusp-tebn (Kimmtrak) (CP.PHAR.575) Policy created. | 02.10.22 | 05.22 | covered if criteria are met | May 1, 2026 | payer document |
| Health Care Service Corporation (BCBS IL, TX, OK, NM, MT) | Antineoplaston Cancer Therapy (MED203.002) | listed, no stance | Jan 1, 2026 | payer document |
| Health Care Service Corporation (BCBS IL, TX, OK, NM, MT) | Immunoglobulin Therapy (RX504.003) | listed, no stance | Jan 1, 2026 | payer document |
| Health Care Service Corporation (BCBS IL, TX, OK, NM, MT) | Oncology and Supportive Care Medications (RX502.061) Code | Generic | Brand | listed, no stance | Jan 1, 2027 | payer document |
| Premera Blue Cross | (effective January 1, 2027) Use of Vascular Endothelial Growth Factor Receptor (VEGF) Inhibitors and Other Angiogenesis Inhibitors in Oncology Treatment (5.01.517) | listed, no stance | Sep 8, 2026 | payer document |
| Premera Blue Cross | Bispecific Antibodies (5.01.650) Page | 10 of 23 | ∞ | listed, no stance | Aug 11, 2026 | payer document |
| Premera Blue Cross | Denosumab Products (5.01.658) | listed, no stance | Jul 1, 2026 | payer document |
| Premera Blue Cross | Immune Checkpoint Inhibitors (5.01.591) Page | 36 of 69 | ∞ | listed, no stance | Aug 11, 2026 | payer document |
| Premera Blue Cross | Miscellaneous Oncology Drugs (5.01.540) Page | 64 of 125 | ∞ | listed, no stance | Oct 1, 2026 | payer document |
| UnitedHealthcare | Denied Drug Codes – Pharmacy Benefit Drugs (for Arizona Only) (CS2026D0990AB) | listed, no stance | Jul 1, 2026 | payer document |
| UnitedHealthcare | Maximum Dosage and Frequency (CS2026D0034AV) | listed, no stance | Aug 1, 2026 | payer document |
| UnitedHealthcare | Maximum Dosage and Frequency (for Ohio Only) (CSOH2026D0034.K) Bilprevda | denosumab-nxxp | 120 mg | C9399 | 120 HCPCS units | listed, no stance | May 1, 2026 | payer document |
| UnitedHealthcare | Medicare Part B Step Therapy Programs (IAP.001.30) Non-Preferred | listed, no stance | Jul 1, 2026 | payer document |
| UnitedHealthcare | Rituximab (Riabni®, Rituxan®, Ruxience® & Truxima®) (for Indiana Only) (CSIND0003.07) | listed, no stance | Aug 1, 2025 | payer document |
| UnitedHealthcare | Rituximab (Riabni®, Rituxan®, Ruxience®, & Truxima®) (2026D0003AO) | listed, no stance | Jan 1, 2026 | payer document |
| UnitedHealthcare | White Blood Cell Colony Stimulating Factors (2026D0061AE) | listed, no stance | Sep 1, 2026 | payer document |
| Wellmark Blue Cross Blue Shield | Anktiva® (nogapendekin alfa inbakicept-pmln) (05.05.49) | listed, no stance | Aug 1, 2026 | payer document |
| Wellmark Blue Cross Blue Shield | Aucatzyl® (obecabtagene autoleucel) (05.05.71) | listed, no stance | Aug 1, 2026 | payer document |
| Wellmark Blue Cross Blue Shield | Bevacizumab (05.04.24) | listed, no stance | Aug 1, 2026 | payer document |
| Wellmark Blue Cross Blue Shield | Bizengri® (zenocutuzumab-zbco) (05.05.80) | listed, no stance | Aug 1, 2026 | payer document |
| Wellmark Blue Cross Blue Shield | Blenrep® (belantamab mafodotin-blmf) (05.06.14) | listed, no stance | Aug 1, 2026 | payer document |
| Wellmark Blue Cross Blue Shield | Inlexzo® (gemcitabine intravesical system) (05.06.19) | listed, no stance | Aug 1, 2026 | payer document |
| Wellmark Blue Cross Blue Shield | Lynozyfic® (linvoseltamab-gcpt) (05.06.01) | listed, no stance | Aug 1, 2026 | payer document |
| Wellmark Blue Cross Blue Shield | Opdualag (nivolumab and relatlimab-rmbw) (05.04.64) | listed, no stance | Aug 1, 2026 | payer document |
| Wellmark Blue Cross Blue Shield | PiaSkyTM (crovalimab) (05.05.52) | listed, no stance | Oct 1, 2025 | payer document |
| Wellmark Blue Cross Blue Shield | Rytelo™(imetelstat) (05.05.51) | listed, no stance | Jun 1, 2026 | payer document |
| Wellmark Blue Cross Blue Shield | Unloxcyt® (cosibelimab-ipdl) (05.05.79) | listed, no stance | Aug 1, 2026 | payer document |
| Wellmark Blue Cross Blue Shield | Zusduri™ (mitomycin) (05.05.97) | listed, no stance | Aug 1, 2026 | payer document |
| Wellmark Blue Cross Blue Shield | Zynyz (retifanlimab-dlwr) (05.04.99) | listed, no stance | Aug 1, 2026 | payer document |
Prior authorization required or conditional in VT, WA.
From payers' published prior-auth lists, coverage policies and state Medicaid fee schedules, updated Oct 16, 2026. The role is what the policy's own code table or text says about the code. Not a guarantee of coverage or payment; verify with the payer. CPT® is a registered trademark of the American Medical Association.